Infographics: Inert vs Conventional UHPLC Analysis of Biomedicals

Chromatography

Infographics: Inert vs Conventional UHPLC Analysis of Biomedicals

16 Jul, 2025

In the realm of biomedical analysis, the choice of Ultra-High Performance Liquid Chromatography (UHPLC) systems can significantly impact the quality and reliability of results. Traditional stainless steel-based UHPLC systems often face challenges such as adsorption of biomolecules to metal surfaces, leading to reduced sensitivity, lower reproducibility, peak tailing, and sample loss. These issues can compromise the accuracy and efficiency of biomolecule analysis.

In contrast, the Nexera XS inert UHPLC system offers a bioinert and biocompatible solution that addresses these common problems. By utilising a metal-free sample flow path, the Nexera XS inert prevents unwanted interactions with biopolymers, ensuring no sample loss and excellent separation. This innovative approach enhances sample recovery, increases sensitivity, improves resolution, and elevates overall efficiency.

The Shimadzu Nexera XS inert system is designed to provide high-quality and reliable data, making it particularly well-suited for the analysis of biopolymers such as antibodies, peptides, and nucleic acid drugs. With its advanced features and corrosion-resistant materials, the Nexera XS inert UHPLC system sets a new standard in biomolecule analysis.

Would you like to find out more about the differences between inert and conventional UHPLC systems? Download the infographics here to explore the benefits and innovations of the Nexera XS inert UHPLC.

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
England's rivers and lakes: what the 2025 data really shows about pollution drivers
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
A single supplier, eight failures: Indonesia's flashpoint problem
Explore more Arrow
Chromatography Today
LC–MS/MS metabolite panel shows potential for breast cancer assessment
Explore more Arrow